Hepatocellular carcinoma in individuals with HBV infection or HBVHCV co-infection in a low endemic country

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 7-8, 2010, Pages 944-952

  Davídłsdóttir, Lóa ^a   Duberg, Ann Sofi ^b   Törner, Anna ^c   Aleman, Soo ^a   Bäck, Erik ^b   Ekdahl, Karl ^d   Blaxhult, Anders ^c   Ekbom, Anders ^e   Hultcrantz, Rolf ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^d EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cancer Registry; Cohort study; Epidemiology; Standardized incidence ratio; Sweden

Indexed keywords

ADULT; AGED; ARTICLE; CANCER REGISTRY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; ENDEMIC DISEASE; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; POPULATION; PRIORITY JOURNAL; RISK; STANDARDIZED INCIDENCE RATIO; SWEDEN;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; SWEDEN;

EID: 77955686439     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521003770251     Document Type: Article

References (41)

1. The global burden of disease: 2004 update. 2004:8-9.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
3. McGlynn KA, Tsao L, Hsing AW, Devesa SS, Fraumeni JF Jr. International trends and patterns of primary liver cancer. Int J Cancer 2001;94:290-296
4. NORDCAN. Association of the Nordic Cancer Registries, 2007.
5. Soderstrom A, Lindh M, Eriksson K, Horal P, Krantz M, Kristiansson B, et al. Chronic hepatitis B in children in Gothenburg, Sweden. Scand J Infect Dis 1999;31:109-114
6. Duberg AS, Torner A, Davidsdottir L, Aleman S, Blaxhult A, Svensson A, et al. Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community-based register study. J Viral Hepat 2008;15:538-550
7. Global Burden Of Hepatitis C Working Group. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 2004;44:20-29
8. Hoffmann G, Berglund G, Elmstahl S, Eriksson S, Verbaan H, Widell A, et al. Prevalence and clinical spectrum of chronic viral hepatitis in a middle- aged Swedish general urban population. Scand J Gastroenterol 2000;35:861-865
9. Verbaan H, Hoffmann G, Lindgren S, Nilsson S, Widell A, Eriksson S. Long-term outcome of chronic hepatitis C infection in a low-prevalence area. Scand J Gastroenterol 1998;33:650-655
10. Widell A, Verbaan H, Wejstal R, Kaczynski J, Kidd- Ljunggren K, Wallerstedt S. Hepatocellular carcinoma in Sweden: its association with viral hepatitis, especially with hepatitis C viral genotypes. Scand J Infect Dis 2000;32: 147-152
11. Shi J, Zhu L, Liu S, Xie WF. A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br J Cancer 2005;92:607-612
12. Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998;75:347-354
13. Kew MC. Interaction between hepatitis B and C viruses in hepatocellular carcinogenesis. J Viral Hepat 2006;13:145-149
14. Lunde AS, Lundeborg S, Lettenstrom GS, Thygesen L, Huebner J. The person-number systems of Sweden, Norway, Denmark, and Israel. Vital Health Stat 1980;2:1-59.
15. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004;11:97-107.
16. Yim HJ, Lok AS. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 2006;43:S173-81.
17. Duberg AS, Nordström M, Törner A, Reichard O, Strauss R, Janzon R, et al. Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection. Hepatology 2005;41:652-659
18. Strauss R, Torner A, Duberg AS, Hultcrantz R, Ekdahl K. Hepatocellular carcinoma and other primary liver cancers in hepatitis C patients in Sweden - a low endemic country. J Viral Hepat 2008;15:531-537
19. Weiland O, Berg JV, Bjorvatn B, Flehmig B, Lundbergh P. Acute viral hepatitis A, B and non-A, non-B in Stockholm in the 1950s and 1970s: a comparison. Infection 1981;9: 268-274
20. Blackberg J, Braconier JH, Widell A, Kidd-Ljunggren K. Long-term outcome of acute hepatitis B and C in an outbreak of hepatitis in 1969-1972. Eur J Clin Microbiol Infect Dis 2000;19:21-26
21. Månsson AS, Moestrup T, Nordenfelt E, Widell A. Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program. Scand J Infect Dis 2000;32:253-258
22. Widell A, Hansson BG, Berntorp E, Moestrup T, Johansson HP, Hansson H, et al. Antibody to a hepatitis C virus related protein among patients at high risk for hepatitis B. Scand J Infect Dis 1991;23:19-24.
23. Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T- lymphotropic viruses. Am J Public Health 1996;86:655-661
24. Jansson A. A multi-step quality control of the Swedish statutory surveillance system for communicable diseases, before and after the implementation of the upgraded computerized reporting system; SmiNet-2. Swedish Institute for Infectious Disease Control, Biostatistics RaP-satDoMEa, 2008.
25. Mattsson B. Cancer Registration in Sweden: studies on completeness and validity of incidence and mortality registers (dissertation). Stockholm, Sweden: Karolinska institutet; 1984.
26. Amin J, Dore GJ, O'Connell DL, Bartlett M, Tracey E, Kaldor JM, et al. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J Hepatol 2006;45:197-203.
27. Shev S, Hermodsson S, Lindholm A, Malm E, Widell A, Norkrans G. Risk factor exposure among hepatitis C virus RNA positive Swedish blood donors-the role of parenteral and sexual transmission. Scand J Infect Dis 1995;27:99-104.
28. Libbrecht L, Roskams T. Molecular diagnostic approach to liver tissue as an ancillary tool for liver histopathology. Semin Liver Dis 2006;26:328-336
29. Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi DF, et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med 2006;12:410-416
30. Lee JS, Chu IS, Heo J, Calvisi DF, Sun Z, Roskams T, et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 2004;40:667-676 (Pubitemid 39265589)
31. Durnez A, Verslype C, Nevens F, Fevery J, Aerts R, Pirenne J, et al. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology 2006;49:138-151
32. Ding SJ, Li Y, Tan YX, Jiang MR, Tian B, Liu YK, et al. From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis. Mol Cell Proteomics 2004;3:73-81.
33. Dodd RY, Nath N. Increased risk for lethal forms of liver disease among HBsAg-positive blood donors in the United States. J Virol Methods 1987;17:81-94.
34. Hepatitis B virus. IARC Monogr Eval Carcinog Risks Hum 1994;59:45-164.
35. Hall AJ, Winter PD, Wright R. Mortality of hepatitis B positive blood donors in England and Wales. Lancet 1985;1:91-93
36. Duberg AS, Nordstrom M, Torner A, Reichard O, Strauss R, Janzon R, et al. Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection. Hepatology 2005;41:652-659
37. Bissell DM. Sex and hepatic fibrosis. Hepatology 1999; 29(3):988-989
38. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003;139:817-823
39. Stokkeland K, Brandt L, Ekbom A, Osby U, Hultcrantz R. Morbidity and mortality in liver diseases in Sweden 1969-2001 in relation to alcohol consumption. Scand J Gastroenterol 2006;41:459-464
40. Thio CL. Hepatitis B and human immunodeficiency virus coinfection. Hepatology 2009;49:S138-45.
41. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295: 65-73.